Cryoport: Picks And Shovels For The Gene Therapy Boom [Seeking Alpha]
CryoPort (NASDAQ:CYRX) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
How the Story Behind Cryoport Is Evolving After Recent Analyst and Market Developments [Yahoo! Finance]
CryoPort (NASDAQ:CYRX) had its "buy" rating reaffirmed by analysts at UBS Group AG.
CryoPort (NASDAQ:CYRX) had its price target raised by analysts at Needham & Company LLC from $11.00 to $12.00. They now have a "buy" rating on the stock.